This Week at FDA: FDA approves first FMT product, upcoming mpox guidance, and more

Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. This week, we saw FDA approve the first fecal microbiota product, halt the emergency authorization of a COVID-19 antibody and advance guidance on the development of treatments for mpox.